Actio Biosciences
@actiobiosciences.com
At Actio, we are leveraging advances in genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare and common diseases. We are applying expertise in genetics, drug discovery, and data sciences to pinpoint targets that not only cause rare diseases with high unmet need, but that also hold promise in more common indications.
Actio Biosciences's Company Logos
Actio Biosciences's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#8393A2
Regent Gray
131, 147, 162
209, 14, 57
19, 9, 0, 36
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#14477F
Chathams Blue
20, 71, 127
211, 73, 29
84, 44, 0, 50
About Actio Biosciences
Actio Biosciences is a pioneering precision medicine company founded by leaders in genetics and drug development to revolutionize the translation of genetic insights into novel medicines. They specialize in developing therapeutics for both homogenous rare disease populations and heterogeneous common disease populations. With a team of experts including CEO and Co-founder David Goldstein, a renowned human geneticist, Actio is at the forefront of genetic research.
They aim to bring meaningful new therapies from one to many by leveraging their unique approach. The team also includes industry veterans like Co-founder John McHutchison, with extensive experience in clinical development. With a focus on precision and innovation, Actio Biosciences is dedicated to transforming medicine through cutting-edge research and development.
Their team's expertise spans various therapeutic areas, ensuring a comprehensive approach to drug discovery and development
Company type
Privately Held
Year founded
2021
Company size
11-50 employees
Related Brands
Tags
Precision medicines
Rare disease drug development
Small-molecule inhibitors
Mendelian genetics
Genetically defined epilepsy
